Medicare billing address
CMS Medicare provider billing file
640 E 700 SSuite 105
St George, UT 84770
CMS public data · NPI 1568428357
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Mustufa T Saifee, M.D.
Specialty
Credential
M.D.
NPI
1568428357
Primary source state
UT
Data retrieval date
July 26, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Mustufa T Saifee, M.D. from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
640 E 700 SCMS Doctors & Clinicians file
1380 E Medical Ctr DrCMS Doctors & Clinicians file
1380 E Medical Ctr DrCMS Doctors & Clinicians file
1301 Bertha Howe AveIn the 2024 CMS provider billing file, this NPI had 1,595 Medicare beneficiaries and 4,140 total services. The average beneficiary age was 76, and the average HCC risk score was 1.6.
Total Medicare allowed amount
$489,734.20
Total Medicare payment amount
$363,025.81
Medicare beneficiaries
1,595
Total services
4,140
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
75%
CMS beneficiary-panel share
Ischemic heart disease
39%
CMS beneficiary-panel share
COPD
38%
CMS beneficiary-panel share
Mood disorders
32%
CMS beneficiary-panel share
Chronic kidney disease
31%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 1,249 | $86.33 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 813 | $121.81 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 442 | $36.13 |
| Test to examine how well the lungs exchange gases | 441 | $52.14 |
| Test to determine lung volumes using sensors | 437 | $51.69 |
| Sleep study in sleep lab (6 years or older) | 151 | $576.14 |
| New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 144 | $159.50 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 104 | $602.17 |
| Critical care, first 30-74 minutes | 81 | $202.06 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 80 | $111.06 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1568428357. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Opsumit | Macitentan | 76 | 76 | $949,693.99 |
| 2 | Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 52 | 78 | $49,119.24 |
| 3 | Prednisone | Prednisone | 35 | 47 | $134.69 |
| 4 | Omeprazole | Omeprazole | 27 | 64 | $373.68 |
| 5 | Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 26 | 32 | $15,199.09 |
| 6 | Montelukast Sodium | Montelukast Sodium | 25 | 57 | $226.36 |
| 7 | Ofev | Nintedanib Esylate | 24 | 24 | $330,761.97 |
| 8 | Adempas | Riociguat | 18 | 18 | $247,457.10 |
| 9 | Eliquis | Apixaban | 18 | 18 | $6,004.24 |
| 10 | Spiriva Respimat | Tiotropium Bromide | 18 | 28 | $14,790.81 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Graduation year
1990
Group/practice field
Advanced Pulmonary Sleep Disorders And Internal Medicine Pllc
Telehealth reported
Yes
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.